Evidence map›Paper›PMID 31154815›Full record

ArticleCirculation2019

Novel Role for the AnxA1-Fpr2/ALX Signaling Axis as a Key Regulator of Platelet Function to Promote Resolution of Inflammation.

Elena Y Senchenkova, Junaid Ansari, Felix Becker, Shantel A Vital, Zaki Al-Yafeai, Erica M Sparkenbaugh, Rafal Pawlinski, Karen Y Stokes, Jennifer L Carroll, Ana-Maria Dragoi and 10 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Circulation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 161 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. M2 Macrophage-Derived Extracellular Vesicles Reprogram Immature Neutrophils into Anxa1Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  14. Article
  15. Article
  16. Annexin A1: The dawn of ischemic stroke (Review).Molecular medicine reports · 2025
    Review
  17. Thrombocytopenia in Sepsis.Life (Basel, Switzerland) · 2025
    Review
  18. Article
  19. Review
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 11 institutions in 5 countries.

Elena Y SenchenkovaDepartments of Molecular and Cellular Physiology (E.Y.S., J.A., S.A.V., K.Y.S., D.N.G., F.N.E.G.).
Junaid AnsariDepartments of Molecular and Cellular Physiology (E.Y.S., J.A., S.A.V., K.Y.S., D.N.G., F.N.E.G.).
Felix BeckerDepartment for General, Visceral, and Transplant Surgery, University Hospital Muenster, Germany (F.B., H.S.).
Shantel A VitalDepartments of Molecular and Cellular Physiology (E.Y.S., J.A., S.A.V., K.Y.S., D.N.G., F.N.E.G.).
Zaki Al-YafeaiPathology and Translational Pathobiology (Z.A.-Y., A.W.O.).
Erica M SparkenbaughDepartment of Medicine, University North Carolina Chapel Hill (E.M.S., R.P.).
Rafal PawlinskiDepartment of Medicine, University North Carolina Chapel Hill (E.M.S., R.P.).
Karen Y StokesDepartments of Molecular and Cellular Physiology (E.Y.S., J.A., S.A.V., K.Y.S., D.N.G., F.N.E.G.).
Jennifer L CarrollINLET (J.L.C., A.-M.D.).
Ana-Maria DragoiINLET (J.L.C., A.-M.D.).
Cheng Xue QinHeart Failure Pharmacology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia (C.X.Q., R.H.R.).
Rebecca H RitchieHeart Failure Pharmacology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia (C.X.Q., R.H.R.).
Hai SunNeurosurgery (H.S., H.H.C.-Z.).
Hugo H Cuellar-SaenzNeurosurgery (H.S., H.H.C.-Z.).
Mara R RubinsteinDivision of Periodontics, College of Dental Medicine (M.R.R., Y.W.H.), Columbia University, New York.
Yiping W HanDivision of Periodontics, College of Dental Medicine (M.R.R., Y.W.H.), Columbia University, New York.
A Wayne OrrPathology and Translational Pathobiology (Z.A.-Y., A.W.O.).
Mauro PerrettiWilliam Harvey Research Institute, Queen Mary University of London, UK (M.P.).
D Neil GrangerDepartments of Molecular and Cellular Physiology (E.Y.S., J.A., S.A.V., K.Y.S., D.N.G., F.N.E.G.).
Felicity N E GavinsDepartments of Molecular and Cellular Physiology (E.Y.S., J.A., S.A.V., K.Y.S., D.N.G., F.N.E.G.).
Baker Heart and Diabetes Institute · AULouisiana State University Health Sciences Center Shreveport · USUniversity Hospital Münster · DEBrunel University of London · GBCellular Research (United States) · USColumbia University · USIvchenko Progress (Ukraine) · UANew York University · USPath BioAnalytics (United States) · USQueen Mary University of London · GBUniversity of North Carolina at Chapel Hill · US

Funding

Stress Exacerbates Myocardial Ischemic Injury by Blocking Estrogen's Antidoxidant Protection in the Female HeartP20GM121307 · NIGMS · LOUISIANA STATE UNIV HSC SHREVEPORT · PI Vesna Tesic · 2018 to 2026
$23.6M
Nck Adaptor Proteins in Atherogenic Endothelial ActivationR01HL133497 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI ORR, ANTHONY WAYNE · 2016 to 2024
$3.8M
Matrix Signaling in Endothelial Cell DysfunctionR01HL098435 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI ORR, ANTHONY WAYNE · 2010 to 2020
$3.2M
EphA2 signaling in atherosclerotic fibroproliferative remodelingR01HL141155 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI ORR, ANTHONY WAYNE · 2019 to 2022
$1.8M
Mechanisms of coagulation-dependent pathologies in sickle cell diseaseR01HL142604 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PAWLINSKI, RAFAL L · 2018 to 2021
$1.6M
Investigating the dysfunction of the cerebral microvasculature in sickle cell diseaseR01HL134959 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI STOKES, KAREN Y · 2017 to 2020
$1.4M
NHLBI NIH HHS R01 HL098435NHLBI NIH HHS R01 HL133497NHLBI NIH HHS R01 HL134959NHLBI NIH HHS R01 HL141155NHLBI NIH HHS R01 HL142604NIGMS NIH HHS P20 GM121307Wellcome Trust 086867/Z/08/Z
6 · The paper itself

Abstract

backgroundIschemia reperfusion injury (I/RI) is a common complication of cardiovascular diseases. Resolution of detrimental I/RI-generated prothrombotic and proinflammatory responses is essential to restore homeostasis. Platelets play a crucial part in the integration of thrombosis and inflammation. Their role as participants in the resolution of thromboinflammation is underappreciated; therefore we used pharmacological and genetic approaches, coupled with murine and clinical samples, to uncover key concepts underlying this role.

methodsMiddle cerebral artery occlusion with reperfusion was performed in wild-type or annexin A1 (AnxA1) knockout (AnxA1

resultsIntravital microscopy revealed heightened platelet adherence and aggregate formation post I/RI, which were further exacerbated in AnxA1

Indexed as

AgedAged, 80 and overAnimalsAnnexin A1Blood PlateletsFemaleHumansInfarction, Middle Cerebral ArteryInflammationMaleMiceMiddle AgedSignal TransductionAnnexin A1annexin A1, mouseannexin A1formyl peptide receptorinflammationintegrinsstrokethrombosis

Identifiers

PMID31154815
PMCPMC6687438
OpenAlexW2948033422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.